ADR Sign up for ETOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanemaaijer, R
Right arrow Articles by van Hinsbergh, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanemaaijer, R
Right arrow Articles by van Hinsbergh, V.
Advances in Dental Research, Vol 12, Issue 2, 114-118
Copyright © 1998 by International & American Associations for Dental Research


Articles

Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells

R Hanemaaijer, H Visser, P Koolwijk, T Sorsa, T Salo, LM Golub, and VW van Hinsbergh

Gaubius Laboratory TNO-PG, Leiden, The Netherlands.

Doxycycline is a commonly used broad-spectrum antibiotic. Recently, it has been shown that it also inhibits the activity of mammalian collagenases and gelatinases, an activity unrelated to its antimicrobial efficacy. In this study, we show that doxycycline not only inhibits MMP-8 and MMP-9 (gelatinase B) activity, but also the synthesis of MMPs in human endothelial cells. Doxycycline (50 microM) completely inhibited the phorbol-12-myristate-13-acetate (PMA)-mediated induction of MMP-8 and MMP-9, as measured by Western blotting and gelatin zymography, respectively. The inhibition was also observed at the mRNA level. No effect was observed on the expression of MMP-2 and of the MMP inhibitors TIMP-1 and TIMP-2. Chemically modified tetracyclines (CMTs) showed an inhibition similar to that of doxycycline, albeit less efficient. These observations demonstrate that endothelial cells display a specific regulation of MMPs, which may have implications for the pharmaceutical interaction in angiogenesis and angiogenesis-related diseases.


This article has been cited by other articles:


Home page
HypertensionHome page
F. A. DeLano and G. W. Schmid-Schonbein
Proteinase Activity and Receptor Cleavage: Mechanism for Insulin Resistance in the Spontaneously Hypertensive Rat
Hypertension, August 1, 2008; 52(2): 415 - 423.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
V A Smith, D Khan-Lim, L Anderson, S D Cook, and A D Dick
Does orally administered doxycycline reach the tear film?
Br. J. Ophthalmol., June 1, 2008; 92(6): 856 - 859.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
S. P. Arnoczky, M. Lavagnino, M. Egerbacher, O. Caballero, and K. Gardner
Matrix Metalloproteinase Inhibitors Prevent a Decrease in the Mechanical Properties of Stress-Deprived Tendons: An In Vitro Experimental Study
Am. J. Sports Med., May 1, 2007; 35(5): 763 - 769.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. W Yeh, J.-P. Rougier, J.-W. Park, Q.-Y. Duh, M. Wong, Z. Werb, and O. H Clark
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1173 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Franco, B. Ho, D. Mulholland, G. Hou, M. Islam, K. Donaldson, and M. P. Bendeck
Doxycycline Alters Vascular Smooth Muscle Cell Adhesion, Migration, and Reorganization of Fibrillar Collagen Matrices
Am. J. Pathol., May 1, 2006; 168(5): 1697 - 1709.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H.-S. Kim, L. Luo, S. C. Pflugfelder, and D.-Q. Li
Doxycycline Inhibits TGF-{beta}1-Induced MMP-9 via Smad and MAPK Pathways in Human Corneal Epithelial Cells
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 840 - 848.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Syed, C. Takimoto, M. Hidalgo, J. Rizzo, J. G. Kuhn, L. A. Hammond, G. Schwartz, A. Tolcher, A. Patnaik, S. G. Eckhardt, et al.
A Phase I and Pharmacokinetic Study of Col-3 (Metastat), an Oral Tetracycline Derivative with Potent Matrix Metalloproteinase and Antitumor Properties
Clin. Cancer Res., October 1, 2004; 10(19): 6512 - 6521.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
V A Smith and S D Cook
Doxycycline--a role in ocular surface repair
Br. J. Ophthalmol., May 1, 2004; 88(5): 619 - 625.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. Krakauer and M. Buckley
Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines
Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3630 - 3633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. M. Islam, C. D. Franco, D. W. Courtman, and M. P. Bendeck
A Nonantibiotic Chemically Modified Tetracycline (CMT-3) Inhibits Intimal Thickening
Am. J. Pathol., October 1, 2003; 163(4): 1557 - 1566.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Axisa, I. M. Loftus, A. R. Naylor, S. Goodall, L. Jones, P. R.F. Bell, M. M. Thompson, and C. Napoli
Prospective, Randomized, Double-Blind Trial Investigating the Effect of Doxycycline on Matrix Metalloproteinase Expression Within Atherosclerotic Carotid Plaques * Editorial Comment
Stroke, December 1, 2002; 33(12): 2858 - 2864.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. P. Bendeck, M. Conte, M. Zhang, N. Nili, B. H. Strauss, and S. M. Farwell
Doxycycline Modulates Smooth Muscle Cell Growth, Migration, and Matrix Remodeling after Arterial Injury
Am. J. Pathol., March 1, 2002; 160(3): 1089 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Buckley, B. Driscoll, W. Shi, K. Anderson, and D. Warburton
Migration and gelatinases in cultured fetal, adult, and hyperoxic alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L427 - L434.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
I. I. Kuzin, J. E. Snyder, G. D. Ugine, D. Wu, S. Lee, T. Bushnell Jr, R. A. Insel, F. M. Young, and A. Bottaro
Tetracyclines inhibit activated B cell function
Int. Immunol., July 1, 2001; 13(7): 921 - 931.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. A. Rudek, W. D. Figg, V. Dyer, W. Dahut, M. L. Turner, S. M. Steinberg, D. J. Liewehr, D. R. Kohler, J. M. Pluda, and E. Reed
Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
J. Clin. Oncol., January 15, 2001; 19(2): 584 - 592.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Tronc, Z. Mallat, S. Lehoux, M. Wassef, B. Esposito, and A. Tedgui
Role of Matrix Metalloproteinases in Blood Flow-Induced Arterial Enlargement : Interaction With NO
Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20 (12): e120 - e126.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 1998 Institutional Access Guidelines